CO6190612A2 - Derivados heterociclicos como receptores muscarinicos m3 - Google Patents
Derivados heterociclicos como receptores muscarinicos m3Info
- Publication number
- CO6190612A2 CO6190612A2 CO09078490A CO09078490A CO6190612A2 CO 6190612 A2 CO6190612 A2 CO 6190612A2 CO 09078490 A CO09078490 A CO 09078490A CO 09078490 A CO09078490 A CO 09078490A CO 6190612 A2 CO6190612 A2 CO 6190612A2
- Authority
- CO
- Colombia
- Prior art keywords
- aryl
- group
- alkyl
- cycloalkyl
- heterocycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
1.- Un compuesto de la fórmula (I):dondeR2 es un grupo H -(Z)p-R7, -Z-Y-R7 o -Y-R7;p es 0 ó 1;R4 y R5 son independientemente seleccionados del grupo que consiste en aril, heterocicloalquil fusionado con aril, heteroaril, C1-C6-alquil y cicloalquil; R6 es -OH, C1-C6-alquil, C1-C6-alcoxi, hidroxi-C1-C6-alquil, nitrilo, un grupo CONR1R9 o un átomo de hidrógeno; uno de W, V y A es N o NR11; otro de W, V y A es N, O, S o CR8; y el último de W, V y A es N o CR8;X es un grupo C1-C4-alquileno, C2-C4-alquenileno o C2-C4-alquinileno; R7 es un grupo C1-C6-alquil, C2-C6-alquenil, aril, cicloalquil fusionado con aril, heterocicloalquil fusionado con aril, heteroaril, aril(C1-C8-alquil)-, heteroaril(C1-C8-alquil)-, heterocicloalquil o cicloalquil; t, u y v son independientemente seleccionados de 1, 2 ó 3, con la condición de que t, u y v no puedan todos ser simultáneamente 1; Z es un grupo C1-C4-alquileno, C2-C4-alquenileno o C2-C4-alquinileno; Y es un átomo de oxígeno, un grupo -OC(O)-, un grupo -N(H)C(O)- o un grupo -S(O)n;n es 0, 1 ó 2; R1, R8, R9 y R11 son, independientemente, un átomo de hidrógeno o un grupo C1-C6-alquil; y D- es un contraión farmacéuticamente aceptable; donde, a menos que se indique lo contrario, cada aparición de alquil, alquenil, heterocicloalquil, aril, heterocicloalquil fusionado con aril, heteroaril, cicloalquil, alcoxi, alquileno, alquenileno, alquinileno o cicloalquil fusionado con aril puede ser opcionalmente sustituida; y donde cada cadena de alquenileno contiene, donde sea posible, hasta 2 enlaces dobles carbono-carbono y cada cadena de alquinileno contiene, donde sea posible, hasta 2 enlaces triples carbono-carbono.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0702994A GB0702994D0 (en) | 2007-02-15 | 2007-02-15 | Compound and thier use |
| GB0722678A GB0722678D0 (en) | 2007-11-19 | 2007-11-19 | Compounds and their use II |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6190612A2 true CO6190612A2 (es) | 2010-08-19 |
Family
ID=39323641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09078490A CO6190612A2 (es) | 2007-02-15 | 2009-07-28 | Derivados heterociclicos como receptores muscarinicos m3 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20100056565A1 (es) |
| EP (1) | EP2121688A1 (es) |
| JP (1) | JP2010519193A (es) |
| KR (1) | KR20090110353A (es) |
| CN (1) | CN101657452A (es) |
| AR (1) | AR065344A1 (es) |
| AU (1) | AU2008215924B2 (es) |
| BR (1) | BRPI0807913A2 (es) |
| CA (1) | CA2676581A1 (es) |
| CL (1) | CL2008000474A1 (es) |
| CO (1) | CO6190612A2 (es) |
| EC (1) | ECSP099573A (es) |
| IL (1) | IL199971A0 (es) |
| MX (1) | MX2009008323A (es) |
| NZ (1) | NZ578489A (es) |
| PE (1) | PE20090357A1 (es) |
| RU (1) | RU2009133258A (es) |
| SA (1) | SA08290066B1 (es) |
| TW (1) | TW200843759A (es) |
| UY (1) | UY30916A1 (es) |
| WO (1) | WO2008099186A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
| WO2009098453A1 (en) * | 2008-02-06 | 2009-08-13 | Astrazeneca Ab | Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists |
| EP2300464A1 (en) | 2008-05-13 | 2011-03-30 | AstraZeneca AB | Quinuclidine derivatives as muscarinic m3 receptor antagonists |
| GB0814728D0 (en) * | 2008-08-12 | 2008-09-17 | Argenta Discovery Ltd | New combination |
| WO2010018352A1 (en) * | 2008-08-12 | 2010-02-18 | Argenta Discovery Limited | Heterocyclic compounds used in the treatment of diseases where enhanced m3 receptor activation is implicated |
| GB0814729D0 (en) * | 2008-08-12 | 2008-09-17 | Argenta Discovery Ltd | New combination |
| WO2010019099A1 (en) * | 2008-08-12 | 2010-02-18 | Astrazeneca Ab | 2-hydroxy-ethanesulfonate salt |
| TW201036957A (en) | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
| CN104418851A (zh) * | 2013-09-02 | 2015-03-18 | 上海龙翔生物医药开发有限公司 | 奎宁环衍生物的制备方法及纯化方法 |
| US9844549B2 (en) * | 2014-08-26 | 2017-12-19 | Astellas Pharma Inc. | 2-aminothiazole derivative or salt thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
| NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
| IL88846A0 (en) * | 1988-01-08 | 1989-07-31 | Merck Sharp & Dohme | Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them |
| GB9603755D0 (en) * | 1996-02-22 | 1996-04-24 | Pfizer Ltd | Therapeutic agents |
| DE19856475A1 (de) * | 1998-11-27 | 2000-05-31 | Schering Ag | Nichtsteroidale Entzündungshemmer |
| US20020052312A1 (en) * | 2000-05-30 | 2002-05-02 | Reiss Theodore F. | Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists |
| ATE334128T1 (de) * | 2000-12-28 | 2006-08-15 | Almirall Prodesfarma Ag | Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten |
| SI1551835T1 (sl) * | 2002-09-30 | 2007-06-30 | Neurosearch As | Novi 1,4-diazabicikloalkanski derivati, njihova priprava in uporaba |
| DK1551835T3 (da) * | 2002-09-30 | 2007-06-04 | Neurosearch As | Hidtil ukendte 1,4-diazabicycloalkanderivater, deres fremstilling og anvendelse |
| US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| ES2239546B1 (es) * | 2004-03-15 | 2006-12-01 | Almirall Prodesfarma, S.A. | Nuevos esteres de quinuclidina cuaternizados. |
| GB0516313D0 (en) * | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
-
2008
- 2008-02-14 JP JP2009549470A patent/JP2010519193A/ja active Pending
- 2008-02-14 CL CL200800474A patent/CL2008000474A1/es unknown
- 2008-02-14 TW TW097105181A patent/TW200843759A/zh unknown
- 2008-02-14 RU RU2009133258/04A patent/RU2009133258A/ru not_active Application Discontinuation
- 2008-02-14 MX MX2009008323A patent/MX2009008323A/es active IP Right Grant
- 2008-02-14 EP EP08709410A patent/EP2121688A1/en not_active Withdrawn
- 2008-02-14 CN CN200880012083A patent/CN101657452A/zh active Pending
- 2008-02-14 AU AU2008215924A patent/AU2008215924B2/en not_active Ceased
- 2008-02-14 PE PE2008000323A patent/PE20090357A1/es not_active Application Discontinuation
- 2008-02-14 CA CA002676581A patent/CA2676581A1/en not_active Abandoned
- 2008-02-14 UY UY30916A patent/UY30916A1/es not_active Application Discontinuation
- 2008-02-14 US US12/523,609 patent/US20100056565A1/en not_active Abandoned
- 2008-02-14 KR KR1020097017018A patent/KR20090110353A/ko not_active Application Discontinuation
- 2008-02-14 AR ARP080100627A patent/AR065344A1/es unknown
- 2008-02-14 NZ NZ578489A patent/NZ578489A/en not_active IP Right Cessation
- 2008-02-14 WO PCT/GB2008/000519 patent/WO2008099186A1/en active Application Filing
- 2008-02-14 BR BRPI0807913-7A2A patent/BRPI0807913A2/pt not_active IP Right Cessation
- 2008-02-16 SA SA08290066A patent/SA08290066B1/ar unknown
-
2009
- 2009-07-20 IL IL199971A patent/IL199971A0/en unknown
- 2009-07-28 CO CO09078490A patent/CO6190612A2/es not_active Application Discontinuation
- 2009-08-12 EC EC2009009573A patent/ECSP099573A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2676581A1 (en) | 2008-08-21 |
| RU2009133258A (ru) | 2011-03-20 |
| SA08290066B1 (ar) | 2011-05-14 |
| AU2008215924A1 (en) | 2008-08-21 |
| ECSP099573A (es) | 2009-12-28 |
| CL2008000474A1 (es) | 2008-08-22 |
| JP2010519193A (ja) | 2010-06-03 |
| WO2008099186A8 (en) | 2008-11-13 |
| UY30916A1 (es) | 2008-09-30 |
| IL199971A0 (en) | 2010-04-15 |
| AU2008215924B2 (en) | 2011-04-21 |
| CN101657452A (zh) | 2010-02-24 |
| EP2121688A1 (en) | 2009-11-25 |
| WO2008099186A1 (en) | 2008-08-21 |
| BRPI0807913A2 (pt) | 2014-06-17 |
| TW200843759A (en) | 2008-11-16 |
| PE20090357A1 (es) | 2009-04-01 |
| KR20090110353A (ko) | 2009-10-21 |
| MX2009008323A (es) | 2009-08-13 |
| NZ578489A (en) | 2011-05-27 |
| AR065344A1 (es) | 2009-06-03 |
| US20100056565A1 (en) | 2010-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6190612A2 (es) | Derivados heterociclicos como receptores muscarinicos m3 | |
| CR10061A (es) | Derivados de pirimidina | |
| UY32547A (es) | Piperidinas sustituidas como antagonistas de ccr3 | |
| ES2624795T3 (es) | Derivados de N-(heteroaril)-1-heteroaril-1H-indol-2-carboxamidas, su preparación y su aplicación en terapéutica | |
| CR11245A (es) | Mejoras en compuestos organicos o relacionadas con los mismos | |
| AR045234A1 (es) | Metodo para producir derivados del almidon de hidroxialquilo y composiciones farmaceuticas que los contienen. | |
| CO6290658A2 (es) | Derivados de azetidina y ciclobutano como inhibidores de jack | |
| ECSP088255A (es) | Derivados de biciclo [2.2.1] hept-7-ilamina y sus usos | |
| PA8852101A1 (es) | Nucleótidos uracil ciclopropílicos | |
| UY29016A1 (es) | Analogos de dipeptidos inhibidores de la hepatitis c | |
| AR044874A1 (es) | Derivados de 4- cianopirazol-3 - carboxamida, su preparacion y su aplicacion en terapeutica | |
| AR073520A1 (es) | Antagonistas de receptores opioides perifericos y usos de los mismos | |
| PE20091843A1 (es) | Inhibidores de catepsina c | |
| CO6180507A2 (es) | Derivado de 2-piridincarboxamida que tiene efecto activador de gk | |
| ECSP066911A (es) | Polimorfo cristalino de un acetato de bazedoxifeno | |
| ECSP066991A (es) | 3-(4-heteroarilciclohexilamino)ciclopentanocarboxamidas como moduladores de receptores de quimiocinas | |
| PE20060165A1 (es) | Compuestos con grupo sulfona como inhibidores de secretasa gamma | |
| UY30052A1 (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
| SV2009003348A (es) | Nuevos derivados triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen | |
| AR094123A1 (es) | Compuesto triciclicos | |
| PE20170427A1 (es) | Peptidos como agonistas de la oxitocina | |
| CO5650235A2 (es) | Derivados de imidazol | |
| AR049668A1 (es) | Proceso quimico para preparar esteres de 4,4 - difluorometil - 3 - oxo - butanoico por reaccion entre una amida y un ester. | |
| ECSP11011415A (es) | Piperidinas sustituidas como antagonistas de ccr3. | |
| AR041218A1 (es) | Derivados de indolilo, un proceso para su preparacion, composicion farmaceutica que lo contiene y uso del compuesto para preparar un medicamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |